A detailed history of J. Safra Sarasin Holding Ag transactions in Biogen Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 72,618 shares of BIIB stock, worth $11.5 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
72,618
Previous 65,758 10.43%
Holding current value
$11.5 Million
Previous $15.2 Billion 7.66%
% of portfolio
0.24%
Previous 0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $1.3 Million - $1.62 Million
6,860 Added 10.43%
72,618 $14.1 Billion
Q2 2024

Jul 30, 2024

BUY
$190.52 - $236.72 $12.5 Million - $15.6 Million
65,758 New
65,758 $15.2 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.